Champions Oncology GAAP EPS of -$0.02 misses by $0.03, revenue of $13.7M beats by $0.51M

Sep. 08, 2022 4:18 PM ETChampions Oncology, Inc. (CSBR)By: Urvi Shah, SA News Editor
  • Champions Oncology press release (NASDAQ:CSBR): Q1 GAAP EPS of -$0.02 misses by $0.03.
  • Revenue of $13.7M (+21.2% Y/Y) beats by $0.51M.
  • Adjusted EBITDA of $450,000.
  • The Company ended the quarter with a strong cash position of $8.1 million.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.